Ryoko Mabuchi

High serum concentration of L-kynurenine predicts unfavorable outcomes in patients with acute myeloid leukemia

Ryoko Mabuchi, Takeshi Hara, Takuro Matsumoto et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2015 · 41 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, High Serum Concentration +20

Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics

Kenji Fukuno, Takeshi Hara, Hisashi Tsurumi et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2014 · 41 citations

Mixed-phenotype Acute Leukemia, Immunology, Pathology +17

R‐THP‐COP versus R‐CHOP in patients younger than 70 years with untreated diffuse large B cell lymphoma: A randomized, open‐label, noninferiority phase 3 trial

Takeshi Hara, Takeshi Yoshikawa, Hideko Goto et al. · Hematological Oncology · 2018 · 36 citations

Effects of indoleamine 2,3-dioxygenase inhibitor in non-Hodgkin lymphoma model mice

Nobuhiko Nakamura, Takeshi Hara, Masahito Shimizu et al. · International Journal of Hematology · 2015 · 24 citations

Lymphoid Neoplasia, Oncogenic Agent, Medicine +7

CHOP or THP‐COP regimens in the treatment of newly diagnosed peripheral T‐cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin

Yuhei Shibata, Takeshi Hara, Senji Kasahara et al. · Hematological Oncology · 2015 · 14 citations